The current valuation score of Champions Oncology Inc is 8.91, ranking 71 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -36.64, which is -2314.86% below the recent high of 811.43 and -622.54% above the recent low of -264.71.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.